Keywords
MedicineAtrial fibrillationClopidogrelIrbesartanAspirinCardiologyRandomized controlled trialInternal medicine
Related Publications
Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.
17,187 patients entering 417 hospitals up to 24 hours (median 5 hours) after the onset of suspected acute myocardial infarction were randomised, with placebo control, between: (...
Natural History of Asymptomatic Mitral Valve Prolapse in the Community
Background— The outcome of mitral valve prolapse (MVP) is controversial, with marked discrepancies in reported complication rates. Methods and Results— We conducted a community ...
Effect of Antihypertensive Treatment in Patients Having Already Suffered From Stroke
Background and Purpose Drug treatment of high blood pressure has been shown to reduce the associated cardiovascular risk. Stroke represents the type of event more strongly linke...
Publication Info
- Year
- 2006
- Type
- article
- Volume
- 367
- Issue
- 9526
- Pages
- 1903-1912
- Citations
- 1942
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1942
OpenAlex
Cite This
Stuart Connolly,
Janice Pogue,
Robert G. Hart
et al.
(2006).
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.
The Lancet
, 367
(9526)
, 1903-1912.
https://doi.org/10.1016/s0140-6736(06)68845-4
Identifiers
- DOI
- 10.1016/s0140-6736(06)68845-4